Mr Matthew Chung
Busan (Korea (Republic of))
When will be appropriate time for P2Y12 inhibitors dose de-escalation?
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Coronary artery disease: pharmacotherapy
ESC 365 is supported by
